Dialog Box

Loading...

2018 Opportunities

Find out about available and upcoming funding opportunities, including project grants and fellowships.

 

Cure Brain Cancer Foundation funds research grants designed to meaningfully and quickly improve survival outcomes for people with brain cancer.

 

Infrastructure Grants 2018
Innovation Grants 2018 
Immunotherapy Trial Grant (now open) 2018 
Fellowship Grants 2019
Innovation Grants 2019 

 2018 INFRASTRUCTURE GRANT

Deadline passed 19 March, 17:00 AEDT

Cure Brain Cancer Foundation's Infrastructure Grant aims to increase the capacity, validity and effectiveness of brain cancer research models systems in Australia. 

This grant will provide support to key research groups that currently develop primary brain cancer model systems and provide these as a resource to other research groups. Model systems are a valuable resource to quality medical research and it is vital that Australian researchers have access to this critical technology to accelerate the number and quality of potential brain cancer agents to clinical trials. 

Successful applications will demonstrate collaboration and mentorship to other groups in Australia and will be prepared to continue to collaborate and build capacity in Australian brain cancer research.

FUNDING DETAILS

This Infrastructure grant-in-aid will provide up to $400,000. That is, up to $100,000 per year for four years.

ELIGIBILITY 

We encourage applications from researchers that provide, and aim to continuously improve models for basic science and translational research of brain cancer and the testing of potential treatments.

Applicants must demonstrate that they have previously provided support and resources to researchers at multiple institutions. Applicants must be prepared to continue to collaborate to increase the scale and quality of Australian brain cancer research through technology and mentorship. 

Principle Investigators must:

  • Undertake this work at an Australian research institution 
  • Have read and agreed to the terms and conditions of funding 
  • Already have established primary brain cancer model systems
  • Already provide brain cancer models and mentorship to external brain cancer research groups in Australia 

2018 INNOVATION GRANT 

Deadline passed 20 April 2018, 17.00 AEST 

 

Innovation Grants aim to fund new research projects that deviate from existing paradigms and current lines of investigation. These grants allow investigators to follow leading observations and exploration of novel ideas in brain cancer research. They support investigators to produce proof-of-concept data for their higher-risk projects and establish feasibility for future research and grant applications.

Funding Details

Innovation Grants-in-aid will offer up to $200,000 over two years.

Eligibility

Principal Investigators must:

Undertake research at an Australian research institution.

Use any awarded funds to work on novel* research applicable to primary brain cancer. 

Have read and agree to the terms and conditions of funding.  

*Truly new (testing new grounds) or which promise results that are significantly advancing science.

  

2018 IMMUNOTHERAPY TRIAL GRANT

Applications open until 20 June 2018 17:00 AEST - APPLY HERE

Cure Brain Cancer Foundation's Immunotherapy Trial Grants-in-aid will provide funding for a clinical study that investigates an immunotherapeutic agent and has the objective of increasing overall survival for patients with primary brain cancer. This clinical trial can focus on any age group.

Funding Details

The Immunotherapy Trial Grant-in-aid will offer up to $500,000 over three years.

Eligibility

Principal Investigators must:

Undertake research at an Australian research institution.

Have at least one trial site in New South Wales.

Investigate an immunotherapeutic agent. 

Have read and agree to the terms and conditions of funding.

IMMUNOTHERAPY TRIAL GRANT APPLICATION PROCESS

APPLY HERE FOR CURE BRAIN CANCER FOUNDATION'S 2018 IMMUNOTHERAPY TRIAL GRANT 

2017 Early Career Fellowship 

Deadline passed 18 August 2017, 17.00 AEST

 

Cure Brain Cancer’s Early Career Fellowships aim to support bright young researchers to develop their career in brain cancer research. Cure Brain Cancer believes that it is important to build capacity in innovative brain cancer research and development to achieve our mission of improving survival for people living with brain cancer. It is expected that Fellows undertake a significant piece of publishable work during their tenure that will lead to a more permanent position within the brain cancer research field.

Funding Details

The Cure Brain Cancer Early Career Fellowship will offer grants-in-aid of up to $115,000 per year for three years. Including up to $100,000 salary (depending on experience and academic level), and $15,000 for research costs, including up to $5,000 for travel and conferences per year.

If the applicant is successful with an NHMRC or Cancer Australia or other Fellowship then this must be disclosed to CBCF and the CBCF contribution will be revised down to an appropriate top-up level depending on individual circumstances.

Eligibility

Applicants must:

     Be eligible to work in Australia for the duration of the award.

     Undertake research at an Australian research institution.

     Have been awarded their PhD within the last six years prior to 30 June in the year of application (i.e. 2017). The start date should be taken from the date the PhD thesis was passed (not the date of degree conferral). Consideration will also be given to final year PhD students, whose PhD will be submitted by December 2017 and approved before Fellowship begins in early 2018. 

     Have a proven track record of research but not held an established academic appointment.

Have read and agree to the terms and conditions of funding.

Donate to fund research like this
Your generous support makes research like this possible. Donate to fund vital brain cancer research. 

Innovation Grant Donors

Thank you to the following supporters for donating to our Innovation program:

Nanette Ainsworth, Geoff Alder, Mirko Angele, Jenny Bacani,  Balance Foundation, Tracey Berger, Jackie & Mikhel Borglund, Kieran Bresnahan, Rachel Brown, Andrew Bullock & Justine Isemonger,  CBA Constructions,  Centre for Minimally Invasive Surgery, Steven Chapman, Mary Joan Cochrane, Joanna Collins, Alex Cullen,  CVA Constructions Pty Ltd, Paul Dainty, Sonya & Andrew Dayman, Louise de Bomford, Frank Dibley, Peter Dowling, Julian Doyle, Tony Doyle, Jo Drinnan, Benn Dullard,  Edt Electrical,  Emohrvo Financial Services, Yvonne Findley, Darren Freeman, Erik Garcia, Natalie Gimour-Jurd, Wayne Glaskin, John Greaves,  Hillross Macarthur, Geoff Hoskin, Cassandra Hunt, Anita Jacoby, Cheryl & Gary James,  Jaycar Electronics, Tommy Tae Johnston, Vijay Jootna, Larry Kestelman, Wendy Lapointe, Bob Laurie, Scott Lavatt, Joshua Lee, Andrew Lennox, John Levin, Michael Lim, Stuart Macdermid, Michael Madigan, Kate Martin, Lucas McEntee, Lucy McGrath, Andrew Mial, Janine Mladin, Fiona Nation, Kristian Nelson-Marshall, William O'Dwyer, Frank Pace, Cath Pasfield,  Payless Tyress, Louise & Mitchell Pether,  Pharmacy Guild NSW, Wal Pisciotta, M Potts, Ann Ramsay Arkins, Joe Redechi, Veronic & Brian Rix, William Robinson, Steven Simpson, Geoff Sparke, Sinead Strawbridge, Luca Tarchi, Jenny Tuntevski, Evenlyn Turco, B A Wilson, Michael Wipfly.

Early Career Fellowship Donors

Thank you to the following supporters for donating to our Early Career Fellowship program:

Anthony Abussi, Nicholas Abussi, Peter Achelles, Stephen Ainsworth, J Anderson, Paul Anderson, Louise Antico, Sally Bell, Beverley Bermeister, Catryna Bilyk, Sue Bishop, Marcus & Caroline Blackmore, Mikael Borglund, Bill Bovingdon, David Bush, Peter Butler, Tracey Cahill, Bill Calcraft, Anita Champion, Khang Chem & Claire Leska, Paul Chiodo, Claire Clayton, Frank & Marisa Colli, Joanna Collins, Ed Cooper, Brian Dean, David & Delora Devonshire, Emily Dowd, Joanne Drinnan, Benn Dullard, Jenny Dyer, Matthew Dyer www.bookwell.com.au, Luke Everingham, Ros Facey, Ivetic Family, David Fenlon, Rebecca Fleming, Andrew Freelander, Darren Freemen, Jack Gance, Jenny & John Gigacz, William Gordon, Kiinda Grange, Ruth Grant, Bennett Griffiths, Rowena Hamilton, Jessica Hansson, Kaye Hansson, Robert Harrison, David Heaney, John Heike, Y A Henry, Ryan Heyes, Paul Hillbrick, Nigel Hokin, Guyon Holland,  Imperial Portfolio Pty Ltd, Bluemouth Interactive, Colin Jackson, Anita Jacoby, Jane Jaggs, Jill Kelly, Wendy Lapointe,  Libra Scale Service, S N Macdermid, Lynne Marchesani, Toni Martin, Nasser Mashni, Matthew McFarland, Carmel McGregor Consulting, Karl Mentzer, Andrew Miall, B J Miall, Sandra Miller, Janine Mladin, Darren Munro, Scott Nowell, Peter Osborne, Francis Pace, Cath Pasfield, Anthony Pearson, Julie Pollard & Linda Yu, Franklin Printing, Richard Quin, Richard Salamon, Charles Saliba, Mark Scarce, Steven Simpson, Debra Singh, Elliot & Krish Smale, Yvone Spothis,  Step Up Renovation Pty Ltd, Peter Strasser, Gregory Symons, Jodie Tatterson, Peta Taylor, Genevieve Teo, David Thodey, Taryn Tobin, Maria Tod, Craig Truscott, Alysha Waye, Cheryl & Chris Waye, Natalie Wheaton.